An American Sickness: How Healthcare Became Big Business and How You Can Take It Back

by Elisabeth Rosenthal

To speed the arrival of generics, the act dictated that applications from makers of copycat drugs to sell their products no longer had to include fresh clinical trials to demonstrate safety and efficacy, but could rely on prior studies done by the makers of the brand drugs.